Abstract:Epidermal keratinocytes synthesize and secrete α‐melanocyte stimulating hormone (α‐MSH) and adrenocorticotropic hormone (ACTH). These act as agonists of the melanocortin 1 receptor expressed on the cell surface of human melanocytes. Binding of these physiological agonists or synthetic α‐MSH analogs to human MC1R activates the cAMP pathway, leading to activation of transcription factors, mainly p53, MITF, and Nrf2. The downstream targets of these transcription factors enhance DNA repair and antioxidant capacities, promote melanocyte survival, and increase eumelanin synthesis. These pleotropic effects confer photoprotection and prevent vitiligo. The physiological role of α‐melanocyte stimulating hormone in regulating integumental pigmentation of many vertebrate species has been recognized since the 1960's. However, its physiological significance for human pigmentation remained enigmatic until the 1990's. α‐Melanocyte stimulating hormone and related melanocortins are synthesized locally in the skin, primarily by keratinocytes, in addition to the pituitary gland, and therefore act as paracrine factors for melanocytes. Human melanocytes express the melanocortin 1 receptor, which recognizes α‐melanocyte stimulating hormone and the related adrenocorticotropic hormone as agonists. This review summarizes the current knowledge of the pleotropic effects of the activated melanocortin 1 receptor that maintain human melanocyte homeostasis by regulating melanogenesis and the response to environmental stressors, mainly solar radiation. Certain allelic variants of the melanocortin 1 receptor gene are associated with specific pigmentary phenotypes in various human populations. Variants associated with red hair phenotype compromise the function of the encoded receptor. Activation of the human melanocortin 1 receptor regulates eumelanin synthesis and enhances DNA damage response of melanocytes to solar radiation and oxidative stressors. We describe how synthetic selective melanocortin 1 receptor agonists can be efficacious as sunless tanning agents, for treatment of vitiligo and photosensitivity disorders, and for prevention of skin cancer, including melanoma.

Signaling Pathways in Melanogenesis

Paracrine Regulation of Melanogenesis

Biology of melanocytes in mammals

Melanin Transfer in the Epidermis: The Pursuit of Skin Pigmentation Control Mechanisms

Coupling of melanocyte signaling and mechanics by caveolae is required for human skin pigmentation

Melanocytes in regenerative medicine applications and disease modeling

Melanin's Journey from Melanocytes to Keratinocytes: Uncovering the Molecular Mechanisms of Melanin Transfer and Processing

Understanding Mechanisms and Key Factors Influencing Melanogenesis for the Management of Melasma: An Updated Review

Recognition of Melanocytes in Immuno-Neuroendocrinology and Circadian Rhythms: Beyond the Conventional Melanin Synthesis

Role of Dermal Factors Involved in Regulating the Melanin and Melanogenesis of Mammalian Melanocytes in Normal and Abnormal Skin

Melanocyte stem cells as potential therapeutics in skin disorders

Melanogenesis and the Targeted Therapy of Melanoma

The biochemistry of melanogenesis: an insight into the function and mechanism of melanogenesis-related proteins

Journey through the spectacular landscape of melanocortin 1 receptor

Role of keratinocyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes

Epigenetic regulation of melanogenesis

Genetic deciphering of the antagonistic activities of the melanin-concentrating hormone and melanocortin pathways in skin pigmentation

Human Melanocyte Biology, Toxicology, and Pathology

Pharmacological induction of skin pigmentation unveils the neuroendocrine circuit regulated by light

Melanocyte lineage dynamics in development, growth and disease

Solar exposure, the melanocyte and melanoma: Survival pathways and molecular mechanisms.